The co-occurrence Guillain-Barré syndrome and inappropriate ADH syndrome in a Rheumatoid arthritis patient

Year 2014, Volume: 19 Issue: 1, 44 - 46, 29.04.2014

Refah Sayın , Ahmet Dülger Mehmet Erkuzu Temel Tombul , Bünyamin Sertoğullarından

Abstract

Rheumatoid Arthritis (RA) is the most frequently seen connective tissue disorder. In RA, the peripheral nervous system involvements including distal sensory or sensorimotor polyneuropathy and entrapment neuropathies are more common than the central nervous system involvements. Guillain-Barré syndrome (GBS), an autoimmune disorder, can be encountered in any age groups. The syndrome of inappropriate secretion of ADH (SIADH) is characterized by the non-physiologic release of ADH, resulting in impaired water excretion with normal sodium excretion that causes hyponatremia. Herein, we present the co-occurrence GBS and SIADH in a RA patient treated with Methotrexate (Mtx). A 57 year-old female developed ascending weakness, starting from the legs and spreading to the arms while having pneumonia. Electromyography findings were consistent with sensorimotor demyelinating polyneuropathy. The laboratory investigations were compatible with SIADH. In conclusion, the SIADH in GBS should be taken into account for RA patients on Mtx. 

Keywords

Methotrexate, Guillain-Barré syndrome, syndrome of inappropriate ADH, Rheumatoid arthritis

References

• Fleming A, Crown JM, Corbett M. Early rheumatoid disease. I. Onset. II. Patterns of joint involvement. Ann Rheum Dis 1976; 35: 357-363.
• Matteson EL, Conn DL. Extraarticular manifestations of rheumatoid arthritis. In: Weisman MH, Weinblatt ME, Louie Js (eds). Treatment of the rheumatic disease: companion to the textbook of rheumatology. Philadelphia: WB Saunders Company 2000; 236-248. Lewis P. Rowland. Merritt’s Neurology. 10th ed. Lippincott Williams and Wilkins Philadelphia: USA; 2000.
• Douglas MR, Winer JB. Guillain BarréSyndrome and its treatment. Expert Rev Neurotherapeutics 2006; 6: 1569-1574.
• Robertson GL. Regulation of arginine, vasopressin in the syndrome of inappropriate antidiuresis. Am J Med 2006; 119: 36.
• Liamis G, Milionis H, Elisaf M. A review of druginduced hyponatremia. Am J Kidney Dis 2008; 52: 1
• Oge AE, Baykan B. Istanbul University Istanbul Faculty of Medicine Neurology Textbook. In: Candan Gurses, Aysen Gokyigit, (eds). 2nd ed. Metabolic Encephalopathy. 2011; 565-566.
• Terui K, Takahashi Y, Sasaki S, et al. Guillain-Barré syndrome mimicking acute methotrexate-associated encephalopathy in an adolescent patient with lymphoblastic lymphoma. J Pediatr Hematol Oncol 2010; 32: 615-616.
• Inoue M, Kojima Y, Shirakashi Y, Kanda M, Shibasaki H. A case of Guillain-Barré syndrome accompanied by syndrome of inappropriate secretion of antidiuretic hormone. Shinkeigaku Rinsho 2010; 50: 710-713.
• Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology 2011; 76: 701-704.
• Inoue M, Kojima Y, Shirakashi Y, Kanda M, Shibasaki H. A case of Guillain-Barré syndrome accompanied by syndrome of inappropriate secretion of antidiuretic hormone. Rinsho Shinkeigaku 2010; 50: 710-713.
• Frahm H, von Hülst M. Increased secretion of vasopressin and edema formation in high dosage methotrexate therapy. Z Gesamte Inn Med 1988; 43: 411-4